Aquestive Therapeutics (AQST) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
AQST slides 6.9% to $3.78, a 1-month low on 1.8x normal volume. Closed at $3.78, -6.90% vs the prior close of $4.06. Day range $3.75–$4.10, opened at $4.10.
AQST daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AQST slides 6.9% to $3.78, a 1-month low on 1.8x normal volume
- Closed at $3.78, -6.90% vs the prior close of $4.06. Day range $3.75–$4.10, opened at $4.10.
- Volume was 5.24M shares, 1.8x its 50-day average of 2.88M — unusually heavy trading.
- Price is -19.8% vs its 50-day average ($4.71) and -11.4% vs its 200-day average ($4.27).
- 52-week range $2.93–$7.55; today's close sits at 18% of that range, 49.9% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — AQST slides 11.9% to $4.06, a 1-month low on 1.9x normal volume
- Closed at $4.06, -11.93% vs the prior close of $4.61. Day range $3.99–$4.72, opened at $4.67.
- Volume was 5.46M shares, 1.9x its 50-day average of 2.80M — unusually heavy trading.
- Price is -13.9% vs its 50-day average ($4.72) and -5.2% vs its 200-day average ($4.28).
- 52-week range $2.93–$7.55; today's close sits at 24% of that range, 46.2% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 14, 2026 — AQST dips 1.3% to $4.61
- Closed at $4.61, -1.28% vs the prior close of $4.67. Day range $4.57–$4.73, opened at $4.73.
- Volume was 1.60M shares, 0.6x its 50-day average of 2.82M — lighter than usual.
- Price is -2.2% vs its 50-day average ($4.71) and +7.4% vs its 200-day average ($4.29).
- 52-week range $2.93–$7.55; today's close sits at 36% of that range, 38.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — AQST dips 2.9% to $4.67
- Closed at $4.67, -2.91% vs the prior close of $4.81. Day range $4.67–$4.81, opened at $4.80.
- Volume was 1.40M shares, 0.5x its 50-day average of 2.84M — lighter than usual.
- Price is -0.5% vs its 50-day average ($4.69) and +8.6% vs its 200-day average ($4.30).
- 52-week range $2.93–$7.55; today's close sits at 38% of that range, 38.1% below the 52-week high.
Oct 12, 2026 — AQST rises 0.6% to $4.81, 7 up days in a row
- Closed at $4.81, +0.63% vs the prior close of $4.78. Day range $4.73–$4.89, opened at $4.77.
- Volume was 957.30K shares, 0.3x its 50-day average of 2.86M — lighter than usual.
- Price is +2.9% vs its 50-day average ($4.68) and +11.7% vs its 200-day average ($4.31).
- 52-week range $2.93–$7.55; today's close sits at 41% of that range, 36.3% below the 52-week high.
- That makes 7 straight gains.
Oct 9, 2026 — AQST rises 0.4% to $4.78, 6 up days in a row
- Closed at $4.78, +0.42% vs the prior close of $4.76. Day range $4.74–$4.97, opened at $4.78.
- Volume was 1.69M shares, 0.6x its 50-day average of 2.85M — lighter than usual.
- Price is +2.7% vs its 50-day average ($4.65) and +10.9% vs its 200-day average ($4.31).
- 52-week range $2.93–$7.55; today's close sits at 40% of that range, 36.7% below the 52-week high.
- That makes 6 straight gains.
Oct 8, 2026 — AQST jumps 3.0% to $4.76, 5 up days in a row
- Closed at $4.76, +3.03% vs the prior close of $4.62. Day range $4.55–$4.85, opened at $4.62.
- Volume was 2.32M shares, 0.8x its 50-day average of 2.86M.
- Price is +2.7% vs its 50-day average ($4.63) and +10.3% vs its 200-day average ($4.32).
- 52-week range $2.93–$7.55; today's close sits at 40% of that range, 37.0% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — AQST ends flat (+0.2%) to $4.62, 4 up days in a row
- Closed at $4.62, +0.22% vs the prior close of $4.61. Day range $4.53–$4.66, opened at $4.58.
- Volume was 1.36M shares, 0.5x its 50-day average of 2.89M — lighter than usual.
- Price is +0.2% vs its 50-day average ($4.61) and +6.9% vs its 200-day average ($4.32).
- 52-week range $2.93–$7.55; today's close sits at 37% of that range, 38.8% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — AQST rises 0.9% to $4.61, 3 up days in a row
- Closed at $4.61, +0.88% vs the prior close of $4.57. Day range $4.46–$4.64, opened at $4.62.
- Volume was 1.21M shares, 0.4x its 50-day average of 2.90M — lighter than usual.
- Price is +0.4% vs its 50-day average ($4.59) and +6.5% vs its 200-day average ($4.33).
- 52-week range $2.93–$7.55; today's close sits at 36% of that range, 38.9% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — AQST rises 0.4% to $4.57
- Closed at $4.57, +0.44% vs the prior close of $4.55. Day range $4.45–$4.61, opened at $4.57.
- Volume was 1.09M shares, 0.4x its 50-day average of 2.94M — lighter than usual.
- Price is -0.1% vs its 50-day average ($4.58) and +5.5% vs its 200-day average ($4.33).
- 52-week range $2.93–$7.55; today's close sits at 35% of that range, 39.5% below the 52-week high.
Oct 2, 2026 — AQST rises 2.5% to $4.55
- Closed at $4.55, +2.48% vs the prior close of $4.44. Day range $4.43–$4.59, opened at $4.53.
- Volume was 2.27M shares, 0.8x its 50-day average of 2.93M.
- Price is -0.2% vs its 50-day average ($4.56) and +4.8% vs its 200-day average ($4.34).
- 52-week range $2.93–$7.55; today's close sits at 35% of that range, 39.7% below the 52-week high.
AQST latest news & SEC filings
Every SEC filing by or about AQST in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Barber Daniel sold 25,000 shares at $4.22 (≈$105.60K) on Oct 15, 2026; now holds 627,317
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Oct 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Barber Daniel sold 25,000 shares at $4.82 (≈$120.49K) on Sep 15, 2026; now holds 652,317
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Korczynski Sherry sold 8,750 shares at $5.22 (≈$45.67K) on Sep 9, 2026
- Korczynski Sherry sold 8,750 shares at $5.22 (≈$45.67K) on Sep 9, 2026
- Korczynski Sherry sold 8,750 shares at $5.22 (≈$45.67K) on Sep 9, 2026
- Korczynski Sherry sold 8,750 shares at $5.22 (≈$45.67K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $13.82M (prior year $10.00M) (+38.1% vs Jun 30, 2025)
- Net income: -$22.86M (prior year -$13.55M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$0.14) (loss widened vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade AQST
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.85% (largest 11.9%).
- Liquidity: about 2.22M shares (≈$8.41M) trade per day on average.
- 52-week position: $3.78 vs a range of $2.93–$7.55 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Daniel Barber sold 25,000 shares on Sep 15, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 14, 2026; 8-K Sep 29, 2026.
- Share count: 125.51M shares outstanding (Aug 7, 2026), +25.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AQST market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.10 | 4.10 | 3.75 | 3.78 | 5.24M |
| Oct 15, 2026 | 4.67 | 4.72 | 3.99 | 4.06 | 5.47M |
| Oct 14, 2026 | 4.73 | 4.73 | 4.57 | 4.61 | 1.60M |
| Oct 13, 2026 | 4.80 | 4.81 | 4.67 | 4.67 | 1.40M |
| Oct 12, 2026 | 4.77 | 4.89 | 4.73 | 4.81 | 957.30K |
| Oct 9, 2026 | 4.78 | 4.97 | 4.74 | 4.78 | 1.69M |
| Oct 8, 2026 | 4.62 | 4.85 | 4.55 | 4.76 | 2.32M |
| Oct 7, 2026 | 4.58 | 4.66 | 4.53 | 4.62 | 1.36M |
| Oct 6, 2026 | 4.62 | 4.64 | 4.46 | 4.61 | 1.21M |
| Oct 5, 2026 | 4.57 | 4.61 | 4.45 | 4.57 | 1.09M |
| Oct 2, 2026 | 4.53 | 4.59 | 4.43 | 4.55 | 2.27M |
| Oct 1, 2026 | 4.60 | 4.61 | 4.43 | 4.44 | 2.68M |
| Sep 30, 2026 | 4.73 | 4.74 | 4.61 | 4.63 | 2.41M |
| Sep 29, 2026 | 4.70 | 4.75 | 4.55 | 4.67 | 1.71M |
| Sep 28, 2026 | 4.64 | 4.78 | 4.57 | 4.75 | 1.27M |
| Sep 25, 2026 | 4.82 | 4.86 | 4.66 | 4.68 | 1.91M |
| Sep 24, 2026 | 4.69 | 4.85 | 4.62 | 4.82 | 3.01M |
| Sep 23, 2026 | 4.92 | 5.01 | 4.70 | 4.70 | 1.95M |
| Sep 22, 2026 | 4.81 | 5.11 | 4.78 | 4.95 | 2.48M |
| Sep 21, 2026 | 4.65 | 4.82 | 4.56 | 4.78 | 2.45M |
About Aquestive Therapeutics
Aquestive Therapeutics (AQST) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WARREN, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1398733.
AQST board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gregory B Brown | Director | Jun 12, 2026 |
| Daniel Barber | President and CEO | Sep 16, 2026 |
| John Cochran | Director | Jun 12, 2026 |
| Abigail L. Jenkins | Director | Jun 12, 2026 |
| Julie Krop | Director | Jun 24, 2026 |
| Timothy E Morris | Director | Jun 12, 2026 |
| Marco Taglietti | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lori J Braender | Corporate Secretary | May 11, 2026 |
| Daniel Barber | President and CEO | Sep 16, 2026 |
| Peter E. Boyd | Chief People Officer | Sep 10, 2026 |
| Melina Cioffi | SVP, Regulatory Affairs | May 18, 2026 |
| Matthew W. Davis | Chief Development Officer | Mar 11, 2026 |
| Matthew J. Greenhawt | Chief Medical Officer | Mar 11, 2026 |
| Cassie Jung | Chief Operating Officer | Sep 8, 2026 |
| Sherry Korczynski | Chief Commercial Officer | Sep 11, 2026 |
| Carl N Kraus | Chief Medical Officer | Oct 17, 2025 |
| A Ernest Jr Toth | Chief Financial Officer | May 7, 2026 |
| Thomas A. Zalewski | Chief Legal Officer | May 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Daniel Barber | Sale | 25,000 | $4.82 |
| Sep 15, 2026 | Daniel Barber | Sale | 25,000 | $4.82 |
| Sep 15, 2026 | Daniel Barber | Sale | 25,000 | $4.82 |
| Sep 15, 2026 | Daniel Barber | Sale | 25,000 | $4.82 |
| Sep 9, 2026 | Sherry Korczynski | Sale | 8,750 | $5.22 |
| Sep 9, 2026 | Sherry Korczynski | Sale | 8,750 | $5.22 |
| Sep 9, 2026 | Sherry Korczynski | Sale | 8,750 | $5.22 |
| Sep 9, 2026 | Sherry Korczynski | Sale | 8,750 | $5.22 |
| Aug 17, 2026 | Daniel Barber | Sale | 25,000 | $4.29 |
| Aug 17, 2026 | Daniel Barber | Sale | 25,000 | $4.29 |
| Aug 17, 2026 | Daniel Barber | Sale | 25,000 | $4.29 |
| Aug 17, 2026 | Daniel Barber | Sale | 25,000 | $4.29 |
| Jul 16, 2026 | Daniel Barber | Sale | 20,369 | $4.00 |
| Jul 16, 2026 | Daniel Barber | Sale | 20,369 | $4.00 |
| Jul 16, 2026 | Daniel Barber | Sale | 20,369 | $4.00 |
AQST financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $44.55M | $-83.78M | -0.78 | $-52.43M |
| Dec 31, 2024 | $57.56M | $-44.14M | -0.51 | $-35.76M |
| Dec 31, 2023 | $50.58M | $-7.87M | -0.13 | $-6.38M |
| Dec 31, 2022 | $47.68M | $-54.41M | -1.12 | $-9.82M |
| Dec 31, 2021 | $50.83M | $-70.54M | -1.85 | $-32.98M |
Latest balance sheet: total assets $132.10M, total liabilities $188.69M, cash $98.49M (as of Jun 30, 2026).
AQST earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $4.41 |
| May 13, 2026 | 8-K Item 2.02 (results) | $4.13 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $4.37 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $6.00 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $3.86 |
| May 12, 2025 | 8-K Item 2.02 (results) | $2.85 |
| Mar 5, 2025 | 8-K Item 2.02 (results) | $2.79 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $3.11 |
| Nov 4, 2024 | 8-K Item 2.02 (results) | $5.15 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AQST
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.